Yamaguchi M., Kimura-Iwasaki K., Akai T., Nakada Y., Nakagawa H.
Research Department, Institute of Pharmacology Research, Development and Medical Science, Nihon Schering K.K. 2-6-64 Nishimiyahara, Yodogawa-ku, Osaka 532, Japan.
Behav Pharmacol. 1991 Jun;2(3):233-240.
Drug discrimination training with terguride, a 9, 10-transdihydrogenated derivative of lisuride, was carried out using a two-lever food-reinforced procedure (FR 10) in rats, to investigate its influence on central dopaminergic (DA) and serotonergic (5-HT) functions. The terguride (0.05mg/kg, i.p.) discrimination was established within 64 +/- 5 training sessions (mean +/- S.E.) and was stably maintained thereafter. Higher doses of terguride could not be used for discriminative training due to response disruption. In generalization tests with terguride, drug-appropriate responding increased dose-dependently and reached levels of 45 and 99% at 0.01 and 0.05mg/kg i.p. The D(2) agonist lisuride at low doses and the DA autoreceptor agonist (-)-3-PPP substituted for terguride. The DA agonist apomorphine and the 5-HT agonist 5-MeO-DMT produced dose-dependent but incomplete substitution. The D(1) agonist SKF38393, the DA antagonist haloperidol, the D(2) antagonist sulpiride, the D(1) antagonist SCH23390, the 5-HT(1A) agonist 8-OH-DPAT, the 5-HT(1B) agonist m-CPP and the 5-HT(2) agonist DOI were not generalized. In antagonism tests, sulpride completely blocked the terguride-appropriate response, but SCH23390 and the 5-HT antagonist methysergide did not. These results indicate that discriminative stimulus properties of terguride in rats are mediated primarily by activation of receptors with characteristics similar to those of presynaptic D(2) autoreceptors.
使用双杠杆食物强化程序(固定比率10,FR 10)在大鼠中开展了与替咕立定(一种利苏瑞肽的9,10 - 反式二氢衍生物)的药物辨别训练,以研究其对中枢多巴胺能(DA)和血清素能(5 - HT)功能的影响。替咕立定(0.05mg/kg,腹腔注射)的辨别在64±5次训练 sessions(均值±标准误)内建立,并在此后稳定维持。由于反应中断,无法使用更高剂量的替咕立定进行辨别训练。在替咕立定的泛化试验中,药物适应性反应呈剂量依赖性增加,腹腔注射0.01和0.05mg/kg时分别达到45%和99%的水平。低剂量的D(2)激动剂利苏瑞肽和DA自身受体激动剂(-)-3 - PPP替代了替咕立定。DA激动剂阿扑吗啡和5 - HT激动剂5 - 甲氧基 - N,N - 二甲基色胺产生了剂量依赖性但不完全的替代。D(1)激动剂SKF38393、DA拮抗剂氟哌啶醇、D(2)拮抗剂舒必利、D(1)拮抗剂SCH23390、5 - HT(1A)激动剂8 - 羟基 - 二苯丙氨酸、5 - HT(1B)激动剂间氯苯哌嗪和5 - HT(2)激动剂DOI均未产生泛化。在拮抗试验中,舒必利完全阻断了替咕立定适应性反应,但SCH23390和5 - HT拮抗剂麦角酰二乙胺未阻断。这些结果表明,替咕立定在大鼠中的辨别刺激特性主要是通过激活与突触前D(2)自身受体特性相似的受体介导的。